Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring

J Clin Hypertens (Greenwich). 2011;13:467–472. ©2011 Wiley Periodicals, Inc. Azilsartan medoxomil (AZL‐M) is a unique angiotensin II receptor blocker (ARB) under development for the treatment of hypertension. To compare this ARB with another in the class, the authors studied the effects of AZL‐M and...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Hypertens (Greenwich)
Main Authors: Sica, Domenic, White, William B., Weber, Michael A., Bakris, George L., Perez, Alfonso, Cao, Charlie, Handley, Alison, Kupfer, Stuart
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Ltd 2011
Subjects:
Original Papers
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108745/
https://ncbi.nlm.nih.gov/pubmed/21762358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00482.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items